{"text": ["Oral", "Semaglutide", "May", "Drive", "Solid", "Growth", "for", "NVO", "Going", "Forward"], "created_at": "2018-03-05 20:55:02"}
{"text": ["Ozempic", "Is", "Expected", "to", "Boost", "GLP-1", "Drug", "Class", "Trajectory", "in", "2018"], "created_at": "2018-03-05 19:20:50"}
{"text": ["Alexion", "Pharmaceuticals:", "Strensiq", "and", "Kanuma", "in", "2017"], "created_at": "2018-03-05 18:45:02"}
{"text": ["Analyst", "Ratings", "and", "Recommendations", "for", "Sanofi"], "created_at": "2018-03-05 15:31:41"}
{"text": ["Victoza", "Continues", "to", "Lead", "in", "the", "GLP-1", "Segment", "in", "2018"], "created_at": "2018-03-05 15:10:02"}
{"text": ["GLP-1", "Drug", "Class", "May", "Continue", "to", "Drive", "Growth", "for", "Novo", "Nordisk"], "created_at": "2018-03-05 13:39:27"}
{"text": ["OZEMPIC\u00ae", "now", "available", "for", "Canadians", "with", "type", "2", "diabetes"], "created_at": "2018-03-05 13:00:00"}
